Back to MORGAN STANLEY MORGAN STANLEY

SUPNSUPN
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in SUPERNUS PHARMACEUTICALS

MORGAN STANLEY holds 876,841 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $40.8M as of 2026-Q2. The position was decreased (-4.0% shares). SUPN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$40.8M

Current Shares

876,841

Total Value Change

+$18.1M

Total Shares Change

+150,728

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
876,841
-4.0%
$40.8M0.0%$46.51
0
2026-Q1
Decreased
913,893
-15.3%
$47.2M0.0%$54.56
0
2025-Q4
Increased
1.1M
+42.9%
$53.6M0.0%$49.89
39
2025-Q3
Increased
755,317
+8.9%
$36.1M0.0%$47.60
32
2025-Q2
Increased
693,752
+6.8%
$21.9M0.0%$31.16
30
2025-Q1
Decreased
649,838
-4.1%
$21.3M0.0%$32.29
0
2024-Q4
Decreased
677,667
-6.7%
$24.5M0.0%$36.91
0
2024-Q3
Increased
726,113
+8.3%
$22.6M0.0%$30.75
31

Other major holders of SUPN: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used